Frank Kung - 20 Sep 2022 Form 4/A - Amendment Insider Report for AMYRIS, INC.

Role
Director
Signature
/s/ Frank Kung by Bruna Lawant Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
20 Sep 2022
Net transactions value
-$2,140,000
Form type
4/A - Amendment
Filing time
23 Sep 2022, 16:20:37 UTC
Date Of Original Report
22 Sep 2022
Previous filing
19 Sep 2022
Next filing
07 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRS Common Stock Sale $1,177,301 -327,028 -67% $3.60 163,512 20 Sep 2022 by Vivo Opportunity Fund Holdings, LP F1, F2, F3
transaction AMRS Common Stock Sale $262,699 -72,972 -67% $3.60 36,488 20 Sep 2022 by Vivo Capital Fund IX, LP F1, F2, F4
transaction AMRS Common Stock Sale $572,292 -163,512 -100% $3.50 0 21 Sep 2022 by Vivo Opportunity Fund Holdings, LP F1, F3, F5
transaction AMRS Common Stock Sale $127,708 -36,488 -100% $3.50 0 21 Sep 2022 by Vivo Capital Fund IX, LP F1, F4, F5
holding AMRS Common Stock 6,796,205 20 Sep 2022 by Vivo Capital Fund VIII, L.P. F6
holding AMRS Common Stock 938,416 20 Sep 2022 by Vivo Capital Surplus Fund VIII, L.P. F6
holding AMRS Common Stock 16,207 20 Sep 2022 by Vivo Capital LLC F7
holding AMRS Common Stock 80,000 20 Sep 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by each of Vivo Capital Fund IX, L.P. and Vivo Opportunity Fund Holdings, L.P. on August 15, 2022. These sales complete this trading plan and there are no additional shares to be sold under this trading plan. As a result of such sales, the remaining beneficial ownership of Vivo affiliates is approximately 2.4%. These sales are part of the portfolio exit plan for these specific Vivo funds.
F2 The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $3.50 to $3.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The General Partner of Vivo Opportunity Fund Holdings, L.P. is Vivo Opportunity, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4 The General Partner of Vivo Capital Fund IX, L.P. is Vivo Capital IX, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with six (6) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F5 The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $3.40 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
F6 The General Partner of Vivo Capital Fund VIII, L.P. and Vivo Capital Surplus Fund VIII, L.P. is Vivo Capital VIII, LLC, of which the Reporting Person is a voting member. The Reporting Person may be deemed to share voting and dispositive power over these shares with four (4) other voting members. The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F7 Pursuant to an agreement dated November 2, 2017 between the Reporting Person and Vivo Capital LLC ("Vivo Capital"), the Reporting Person agreed to remit the equity compensation received under Issuer's non-employee director compensation program to Vivo Capital if and when such equity compensation becomes vested and/or exercised.

Remarks:

This Form 4/A is filed to provide additional information in footnote 1.